Why Switzerland Why Switzerland Incyte, a key player in Western Switzerland’s biopharmaceutical innovation landscape
Headquarters Toblerone strengthens its Swiss roots with CHF 65 million investment in Bern 14 April 2025
Life sciences CHUV’s new Children’s Hospital enhances pediatric care in Western Switzerland 8 April 2025
Life sciences Campus Santé, a landmark investment in Geneva’s future of healthcare and research 7 April 2025
Life sciences Life sciences Jabil, driving medical innovation from the heart of Neuchâtel’s industrial ecosystem 2 April 2025
Headquarters Matis establishes first Swiss office in Geneva to democratize art investment 12 March 2025
Business environment Geneva strengthens its innovation ecosystem with a strategic development plan 10 March 2025